Austria Diabetes Medicine Sales is set to reach $286.61 Million by 2026 from $252.12 Million, will jump by 8.7% per year. Canada, Spain and Italy respectively ranked numbers 2, 3 and 4 in this ranking.

Download as XLS

More about Antidiabetics Industry 2026-2030

Our readers also like:

Insulin in Dosage Market Size Value Per Capita in Austria

US Dollars Per Capita
2011 to 2023
ReportLinker Research

Insulin in Dosage Market Size Value in Austria

US Dollars
2011 to 2023
ReportLinker Research

Forecast: Insulin in Dosage Market Size Value Per Capita in Austria

US Dollars Per Capita
2024 to 2028
ReportLinker Research

Forecast: Insulin in Dosage Market Size Value in Austria

US Dollars
2024 to 2028
ReportLinker Research

Forecast: Diabetes Medicine Sales in Austria

Million US Dollars PPP
2024 to 2028
ReportLinker Research

Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Austria

US Dollars PPP Per Capita
2024 to 2028
ReportLinker Research

Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Austria

Percent of Total Sales
2024 to 2028
ReportLinker Research

Forecast: Systemic Hormonal Preparations Use (Excluding Sex Hormones and Insulins) in Austria

Units (Defined Daily Dosage) Per Thousand Persons Per Day
2024 to 2028
ReportLinker Research

Forecast: Diabetes Medicine Sales in Austria

US Dollars PPP Per Capita
2024 to 2028
ReportLinker Research

Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Austria

Million US Dollars PPP
2024 to 2028
ReportLinker Research

Top Countries about Antidiabetics

Italy
Canada
Germany
Poland
Argentina
United Kingdom
Spain
Austria